A blog about chemistry, drug development, science, and technology
Merck is moving away from a long time approach of internal organic growth to one of strategic acquisitions of small companies.
Merck & Co. keen on small acquisitions: executive - washingtonpost.com:
It will be interesting to keep an eye on this and see how they mange this. THey are getting late into the game and many deals, I’m sure are already in progress s they’ll have their work cut out for them finding those “hidden gems”. So many folks have already done deals I think they are ver many of these hidden gems remaining.
Technorati Tags: Merck, pharma M&A, pharmaceutical deals
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.720 seconds